Evidence map›Paper›PMID 25615639›Full record

ArticlePloS one2015

Isolation and characterization of a "phiKMV-like" bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia.

Zhenhui Cao, Jiancheng Zhang, Yan D Niu, Naizhong Cui, Yongsheng Ma, Fang Cao, Liji Jin, Zhen Li, Yongping Xu

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Viruses · 2024
    Review
  3. Characterization ofFrontiers in microbiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Phage display as a tool for vaccine and immunotherapy development.Bioengineering & translational medicine · 2020
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Zhenhui CaoSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China.
Jiancheng ZhangSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China.
Yan D NiuAlberta Agriculture and Rural Development, Agriculture Centre, Lethbridge, Alberta, Canada.
Naizhong CuiSchool of Life Science, Datong University, Datong, Shanxi, China.
Yongsheng MaCollege of Food Science and Engineering, Dalian Ocean University, Dalian, Liaoning, China.
Fang CaoSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China.
Liji JinSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China; Ministry of Education Center for Food Safety of Animal Origin, Dalian, Liaoning, China.
Zhen LiSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China.
Yongping XuSchool of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning, China; Ministry of Education Center for Food Safety of Animal Origin, Dalian, Liaoning, China.
Dalian University · CNAgriculture Food and Rural Development · CADalian Ocean University · CNDalian University of Technology · CNShanxi Datong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to investigate the potential of using phages as a therapy against hemorrhagic pneumonia in mink both in vitro and in vivo. Five Pseudomonas aeruginosa (P. aeruginosa) strains were isolated from lungs of mink with suspected hemorrhagic pneumonia and their identity was confirmed by morphological observation and 16S rDNA sequence analysis. Compared to P. aeruginosa strains isolated from mink with hemorrhagic pneumonia in 2002, these isolates were more resistant to antibiotics selected. A lytic phage vB_PaeP_PPA-ABTNL (PPA-ABTNL) of the Podoviridae family was isolated from hospital sewage using a P. aeruginosa isolate as host, showing broad host range against P. aeruginosa. A one-step growth curve analysis of PPA-ABTNL revealed eclipse and latent periods of 20 and 35 min, respectively, with a burst size of about 110 PFU per infected cell. Phage PPA-ABTNL significantly reduced the growth of P. aeruginosa isolates in vitro. The genome of PPA-ABTNL was 43,227 bp (62.4% G+C) containing 54 open reading frames and lacked regions encoding known virulence factors, integration-related proteins and antibiotic resistance determinants. Genome architecture analysis showed that PPA-ABTNL belonged to the "phiKMV-like Viruses" group. A repeated dose inhalational toxicity study using PPA-ABTNL crude preparation was conducted in mice and no significantly abnormal histological changes, morbidity or mortality were observed. There was no indication of any potential risk associated with using PPA-ABTNL as a therapeutic agent. The results of a curative treatment experiment demonstrated that atomization by ultrasonic treatment could efficiently deliver phage to the lungs of mink and a dose of 10 multiplicity of infection was optimal for treating mink hemorrhagic pneumonia. Our work demonstrated the potential for phage to fight P. aeruginosa involved in mink lung infections when administered by means of ultrasonic nebulization.

Indexed as

AnimalsDrug Administration RoutesDrug Resistance, BacterialGenetic VectorsGenome, ViralMiceMinkNebulizers and VaporizersPneumonia, BacterialPodoviridaePseudomonas aeruginosaPseudomonas InfectionsSewageSewage

Identifiers

PMID25615639
PMCPMC4304800
OpenAlexW2009817878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.